Quest Magazine

Transition to Independence Act (S.1604)

Akashi Therapeutics Reports Data from Phase 1b-2a Study in Boys with Duchenne Muscular Dystrophy

News: Isis Pharmaceuticals Reports Data from Phase 2 Study in Infants with Spinal Muscular Atrophy

It's Myasthenia Gravis Awareness Month 2015

In recognition of June being National Myasthenia Gravis Awareness Month, MDA is examining the disease from several perspectives. This article offers an overview of signs, symptoms, diagnosis and treatments for myasthenia gravis (MG), as well as information on drugs that people with MG should avoid.

FDA issues draft guidance on developing drugs for Duchenne Muscular Dystrophy

FDA Approves Investigational New Drug Application for ALS Cellular Therapy

Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum

National Endurance Program Actively Recruiting Participants for
 Signature Half / Full Marathon Events this Fall

Large-scale discovery of DMD biomarkers

MDA Summer Camp Celebrates 60 Years of Changing Lives


Sarepta Announces Plans to Submit Rolling NDA for Treatment of Duchenne Muscular Dystrophy